Amla and blood pressure
What 2 graded rows on amla agree on for blood pressure, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Amla page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Amla page, with its PubMed record.
Your question
Amla and blood pressure
2 rows · 231 peopleSplit. 1 row found an improvement and 1 found no difference.
- CGrade C× 1
- ∅No effect× 1
- Rows
- 2
- Trials
- 2
- People
- 231
Where they differ
From the rowsThe best-graded row, grade C, is a randomized trial of 81 people (2020) and found an improvement. 1 row is graded No effect, our grade for adequately powered trials that found no effect.
The row that found no difference ran longer (3 months) than the row that found an improvement (8 weeks).
The row that found no difference is newer (2021) than the row that found an improvement (2020).
The rows
1 improved · 1 no difference- CGrade CBlood pressure as add-on to blood pressure medicines · Improved
RCT · n 81 · 2020 · Adults with uncontrolled hypertension on standard drugs (Iran)
500 mg three times daily (1,500 mg/day) · 8 weeks
Systolic pressure fell 15.6% vs 6.3% with placebo and diastolic 12.3% vs 3.9% (both P<0.001). No side effects were reported.
- ∅No effectBlood pressure as add-on to blood pressure medicines · No difference
RCT · n 150 · 2021 · Adults with essential hypertension on their usual medicines
500 mg twice daily (1,000 mg/day) · 12 weeks
No additional fall in systolic or diastolic pressure versus placebo, and no improvement in lipids, HbA1c, hs-CRP, oxidative markers or arterial stiffness; safety was good.